Melanoma vaccine seen as supportive, not cure-all, says oncologist

A melanoma vaccine is generating global attention, but oncologist Kamil Karpowicz clarifies it is not a cure-all, serving as supportive treatment after surgery to prevent recurrence. The claim of a breakthrough is partially confirmed, with the vaccine's efficacy limited to specific contexts. This matters as it tempers public expectations and highlights the vaccine's role in adjuvant therapy.